JNJ

227.66

+0.42%↑

ISRG

506.75

-3.44%↓

ABT

105.68

-1.73%↓

MDT

100.45

-0.61%↓

A

129.95

-3.48%↓

JNJ

227.66

+0.42%↑

ISRG

506.75

-3.44%↓

ABT

105.68

-1.73%↓

MDT

100.45

-0.61%↓

A

129.95

-3.48%↓

JNJ

227.66

+0.42%↑

ISRG

506.75

-3.44%↓

ABT

105.68

-1.73%↓

MDT

100.45

-0.61%↓

A

129.95

-3.48%↓

JNJ

227.66

+0.42%↑

ISRG

506.75

-3.44%↓

ABT

105.68

-1.73%↓

MDT

100.45

-0.61%↓

A

129.95

-3.48%↓

JNJ

227.66

+0.42%↑

ISRG

506.75

-3.44%↓

ABT

105.68

-1.73%↓

MDT

100.45

-0.61%↓

A

129.95

-3.48%↓

Search

McKesson Corp

Open

BrancheGesundheitswesen

836.97 2.53

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

813.84

Max

847.47

Schlüsselkennzahlen

By Trading Economics

Einkommen

426M

1.2B

Verkäufe

5.3B

103B

KGV

Branchendurchschnitt

25.84

90.422

Dividendenrendite

0.36

Gewinnspanne

1.173

Angestellte

43,000

EBITDA

212M

1.5B

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+13.94% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.36%

2.13%

Nächstes Ergebnis

4. Feb. 2026

Nächste Dividendenausschüttung

1. Apr. 2026

Nächstes Ex-Dividendendatum

2. März 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

787M

103B

Vorheriger Eröffnungskurs

834.44

Vorheriger Schlusskurs

836.97

Nachrichtenstimmung

By Acuity

39%

61%

113 / 352 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

McKesson Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

28. Jan. 2026, 23:51 UTC

Ergebnisse

Correction to Samsung Fourth-Quarter Net Profit Article

28. Jan. 2026, 23:49 UTC

Heiße Aktien

Stocks to Watch: Meta, IBM, Las Vegas Sands, Whirlpool

28. Jan. 2026, 23:19 UTC

Ergebnisse

Samsung's Fourth-Quarter Net Profit Beats Consensus

28. Jan. 2026, 22:43 UTC

Ergebnisse

Waste Management Logs Higher 4Q Profit as Revenue Rises

29. Jan. 2026, 00:00 UTC

Akquisitionen, Fusionen, Übernahmen

Diller's Overture Came Before Warner Unveiled Split Plans, Source Says -- WSJ

29. Jan. 2026, 00:00 UTC

Akquisitionen, Fusionen, Übernahmen

Warner Says CNN Wasn't and Isn't for Sale -- WSJ

29. Jan. 2026, 00:00 UTC

Akquisitionen, Fusionen, Übernahmen

Barry Diller Told Warner Bros. Discovery He Is Interested in Buying CNN -- WSJ

29. Jan. 2026, 00:00 UTC

Akquisitionen, Fusionen, Übernahmen

Barry Diller Approached Warner Bros. Discovery Last Year About Buying CNN, Sources Say -- WSJ

28. Jan. 2026, 23:49 UTC

Market Talk

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

28. Jan. 2026, 23:30 UTC

Market Talk

Tesla to Use Car Factory for Robot Aims -- Market Talk

28. Jan. 2026, 23:28 UTC

Ergebnisse

Microsoft's Earnings Surge, Elevated by Cloud Business -- 3rd Update

28. Jan. 2026, 23:26 UTC

Ergebnisse

Meta Reports Record Sales, Massive Spending Hike on AI Buildout -- 2nd Update

28. Jan. 2026, 23:21 UTC

Ergebnisse

Microsoft Stock Falls Despite Earnings Beat. Cloud Growth Slowed Slightly. -- Barrons.com

28. Jan. 2026, 23:18 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Tesla to Invest $2 Billion in Elon Musk's xAI -- Update

28. Jan. 2026, 22:58 UTC

Ergebnisse

Tesla to Invest $2 Billion in Elon Musk's xAI -- Update

28. Jan. 2026, 22:48 UTC

Market Talk

Woodside Energy Has Form With Conservative Production Guidance -- Market Talk

28. Jan. 2026, 22:45 UTC

Ergebnisse

Samsung Electronics 2025 Net KRW45.207T Vs. Net KRW34.451T >005930.SE

28. Jan. 2026, 22:44 UTC

Ergebnisse

Samsung Electronics 2025 Oper Pft KRW43.601T Vs. Pft KRW32.726T >005930.SE

28. Jan. 2026, 22:43 UTC

Ergebnisse

Samsung Electronics 2025 Rev KRW333.606T Vs. KRW300.871T >005930.SE

28. Jan. 2026, 22:41 UTC

Ergebnisse
Heiße Aktien

Earnings in Focus Wednesday: Microsoft, Tesla, Meta, Starbucks -- WSJ

28. Jan. 2026, 22:41 UTC

Market Talk

Rising AUD Typically Sees Australian Stocks Outperform -- Market Talk

28. Jan. 2026, 22:41 UTC

Ergebnisse

Meta Stock Rises on Strong Earnings. Expenses Are Mounting. -- Barrons.com

28. Jan. 2026, 22:40 UTC

Ergebnisse

Samsung Electronics 4Q Net Profit Beat FactSet-Compiled Consensus

28. Jan. 2026, 22:39 UTC

Ergebnisse

Samsung Electronics 4Q Net KRW19.642T Vs. Net KRW7.754T >005930.SE

28. Jan. 2026, 22:38 UTC

Ergebnisse

Samsung Electronics 4Q Oper Pft KRW20.074T Vs. Pft KRW6.493T >005930.SE

28. Jan. 2026, 22:37 UTC

Ergebnisse

Samsung Electronics 4Q Rev KRW93.837T Vs. KRW75.788T >005930.SE

28. Jan. 2026, 22:35 UTC

Ergebnisse

Microsoft Stock Falls Despite Earnings Beat. Cloud Growth Slowed Slightly. -- Barrons.com

28. Jan. 2026, 22:26 UTC

Market Talk
Ergebnisse

Meta's Rising CapEx is Fueled by High Pay for AI Workers -- Market Talk

28. Jan. 2026, 22:20 UTC

Market Talk

Global Equities Roundup: Market Talk

28. Jan. 2026, 22:20 UTC

Market Talk

Woodside Energy's Oil Assets Blamed for Guidance Miss -- Market Talk

Peer-Vergleich

Kursveränderung

McKesson Corp Prognose

Kursziel

By TipRanks

13.94% Vorteil

12-Monats-Prognose

Durchschnitt 950.45 USD  13.94%

Hoch 1,000 USD

Tief 880 USD

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für McKesson Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

11 ratings

9

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

681.92 / 707.28Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

No Evidence

Langfristig

No Evidence

Stimmung

By Acuity

113 / 352 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat